Rating History for Oyster Point Pharma (OYST) by Piper Sandler
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 11/8/2022 | Joseph Catanzaro | Downgrade | Neutral (Overweight) |
11.00 (15.00) |
8.35 (11.17) |
33.77% | Details |
 |
|||||||
|
|||||||
|
|||||||
